Renaldee AG

Renaldee's lead asset, Solrena®, is a first-in-class, plant-derived active vitamin D therapy for chronic kidney disease (CKD) and osteoporosis. A purified, standardized extract of Solanum glaucophyllum enriched in 1,25-dihydroxyvitamin D3 glycosides, its unique glycoform differentiates it from conventional vitamin D and supports development as a prescription drug, starting with CKD and expanding to osteoporosis. Complementing this, Trisderm is a topical botanical active from Swiss-grown Trisetum flavescens, naturally containing plant-based vitamin D, positioned for skin barrier support, renewal and anti-aging. Requiring no pharma registration, it offers a fast, capital-efficient route to the clean-beauty market, backed by a fully traceable Swiss supply chain.